Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

Gönüllü, Ümit; Üner, Melike; Yener, Gülgün; Karaman, Ecem Fatma; Aydoğmuş, Zeynep

doi:10.1515/acph-2015-0009

Abstract

Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were prepared for the treatment of painful and inflammatory conditions of the skin. Compritol® 888 ATO, Lanette® O and oleic acid were used as solid and liquid lipids. SLN, NLC and NE were found physically stable at various temperatures for 6 months. Case I diffusional drug release was detected as the dominant mechanism indicating Fickian drug diffusion from nanoparticles and nanoemulsion. The highest rate of drug penetration through rat skin was obtained with NE followed by NLC, SLN and a gel formulation. Nanoformulations significantly increased drug penetration through rat skin compared to the gel (p < 0.05). Thus, SLN, NLC and NE of LRX can be suggested for relieving painful and inflammatory conditions of the skin

References

1. The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals (Ed. M. J. O’Neil), 14th ed., Merck Publishing Group, Merck & Co., Inc., Whitehouse Station 2006.
Search in Google Scholar
2. D. S. P. Byrav, B. Medhi, A. Prakash, S. Patyar and S. Wadhwa, Lornoxicam: A newer NSAID, Indian J. Phys. Med. Rehabil. 20 (2009) 27-31.
Search in Google Scholar
3. F. B. Riecke, E. M. Bartels, S. Torp-Pedersen, S. Ribel-Madsen, H. Bliddal, B. Danneskiold-Samsoe and L. Arendt-Nielsen, A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery, Res. Pharm. Sci. 1 (2011) 76-79; DOI: 10.1016/j. rinphs.2011.11.001.
Search in Google Scholar
4. G. Yener, M. Uner, U. Gonullu, S. Yıldırım, P. Kılıc, S. Sağlık Aslan and A. Barla, Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies, Chem. Pharm. Bull. 58 (2010) 1466-1473; DOI: 10.1248/cpb.58.1466.10.1248/cpb.58.1466
Search in Google Scholar
5. M. Uner, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems, Pharmazie 61 (2006) 375-386.
Search in Google Scholar
6. M. Uner and G. Yener, Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives, Int. J. Nanomed. 2 (2007) 289-300.
Search in Google Scholar
7. S. A. Wissing, A. Lippacher and R. H. Muller, Investigations on the occlusive properties of solid lipid nanoparticles (SLN), J. Cosmet. Sci. 52 (2001) 313-324.
Search in Google Scholar
8. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu and X. Yang, Podophyllotoxinloaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.10.1016/j.jconrel.2005.09.052
Search in Google Scholar
9. C. Puglia, P. Blasi, L. Rizza, A. Schoubben, F. Bonina, C. Rossi and M. Ricci, Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation, Int. J. Pharm. 357 (2008) 295-304; DOI: 10.1016/j.ĳ pharm.2008.01.045.
Search in Google Scholar
10. S. Kuchler, N. B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M. M. Yahya, C. Stein and M. Schafer- Korting, 3D-wound healing model: influence of morphine and solid lipid nanoparticles, J. Biotechnol. 148 (2010) 24-30; DOI: 10.1016/j.jbiotec.2010.01.001.10.1016/j.jbiotec.2010.01.001
Search in Google Scholar
11. V. Sanna, G. Caria and A. Mariani, Eff ect of lipid nanoparticles containing fa_ y alcohols having diff erent chain length on the ex vivo skin permeability of econazole nitrate, Powder Technol. 201 (2010) 32-36; DOI: 10.1016/j.powtec.2010.02.035. 10.1016/j.powtec.2010.02.035
Search in Google Scholar
12. E. B. Souto, C. Anselmi, M. Centini and R. H. Muller, Preparation and characterization of n-dodecyl- ferulate-loaded solid lipid nanoparticles (SLNR), Int. J. Pharm. 295 (2005) 261-268; DOI: 10.1016/j.ĳ pharm.2005.02.005.
Search in Google Scholar
13. M. Ghadiri, S. Fatemi, A. Vatanara, D. Doroud, A. R. Najafabadi, M. Darabi and A. A. Rahimi, Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment effi ciency and particle size, Int. J. Pharm. 424 (2012) 128-137; DOI: 10.1016/j.ĳ pharm.2011.12.037.
Search in Google Scholar
14. Y. C. Kuo and H. H. Chen, Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles, Int. J. Pharm. 365 (2009) 206-213; DOI: 10.1016/j.ĳ pharm.2008.08.050.
Search in Google Scholar
15. O. W. Sto_ , A. C. Williams and B. W. Barry, Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen, J. Control. Release 50 (1998) 297-308; DOI: 10.1016/S0168-3659(97)00153-3.10.1016/S0168-3659(97)00153-3
Search in Google Scholar
16. J. L. Ford and P. Timmins, Pharmaceutical Thermal Analysis, Ellis Horwood, Chichester 1989.
Search in Google Scholar
17. B. Siekmann and K. Westesen, Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles, Colloids Surf., B. Biointerfaces 3 (1994) 159-175; DOI: 10.1016/0927-7765(94)80063-4.10.1016/0927-7765(94)80063-4
Search in Google Scholar
18. J. Pardeike, S. Webera, T. Haber, J. Wagner, H. P. Zarfl , H. Plank and A. Zimmer, Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application, Int. J. Pharm. 419 (2011) 329-338; DOI: 10.1016/j.ĳ pharm.2011.07.040.
Search in Google Scholar
19. D. Z. Hou, C. S. Xie, K. J. Huang and C. H. Zhu, The production and characteristics of solid-lipid nanoparticles (SLNs), Biomaterials 34 (2003) 1781-1785; DOI: 10.1016/S0142-9612(02)00578-1.10.1016/S0142-9612(02)00578-1
Search in Google Scholar
20. S. Das, W. K. Ng and R. B. H. Tan, Are nanostructured lipid carriers (NLCs) be_ er that solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole- loaded SLNs and NLCs?, Eur. J. Pharm. Sci. 47 (2012) 139-151; DOI: 10.1016/j.ejps.2012.05.010.10.1016/j.ejps.2012.05.010
Search in Google Scholar
21. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1
Search in Google Scholar
22. R. W. Korsmeyer, R. Gurney, E. M. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35. DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9
Search in Google Scholar
23. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70 (2008) 633-640; DOI: 10.1016/j.ejpb.2008.05.008.10.1016/j.ejpb.2008.05.008
Search in Google Scholar
24. M. Joshi and V. Patravale, Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132; DOI: 10.1016/j.ĳ pharm.2007.05.060.
Search in Google Scholar
25. A. Zur Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism, Eur. J. Pharm. Biopharm. 45 (1998) 149-155; DOI: 10.1016/S0939-6411(97)00150-1.10.1016/S0939-6411(97)00150-1
Search in Google Scholar
26. K. Bhaskar, J. Anbu, V. Ravichandiran, V. Venkatesvarlu and Y. M. Rao, Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies, Lipids Health Dis. 8 (2009) 1-15; DOI: 10.1186/1476-511X-8-6.10.1186/1476-511X-8-6265188119243632
Search in Google Scholar
27. S. K. Jain, M. K. Chourasia, R. Masuriha, V. Soni, A. Jain, N. K. Jain and Y. Gupta, Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery, Drug Deliv. 12 (2005) 207-215; DOI: 10.1080/10717540590952591. 10.1080/1071754059095259116036715
Search in Google Scholar

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

Abstract

Paradigm

My account